Keyword Suggestion
Domain Informations
Ultragenyx.com lookup results from whois.cloudflare.com server:
- Domain created: 2010-03-12T18:52:56Z
- Domain updated: 2021-04-26T04:21:18Z
- Domain expires: 2027-07-27T11:59:59Z 2 Years, 269 Days left
- Website age: 14 Years, 232 Days
- Registrar Domain ID: 1588559037_DOMAIN_COM-VRSN
- Registrar Url: http://www.cloudflare.com
- Registrar WHOIS Server: whois.cloudflare.com
- Registrar Abuse Contact Email:
- Registrar Abuse Contact Phone: Not Available
- Name server:
- BARBARA.NS.CLOUDFLARE.COM
- JOSE.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.27.199
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.27.199)
Spam Check (IP: 104.18.27.199)
Email address with ultragenyx.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
8. [email protected]
Recent Searched Sites
› Mezokovesd.doklist.com (15 seconds ago) / US
› Go.ly (22 seconds ago) / US
› Dermalmd.com (1 seconds ago) / US
› Edelviz.de (24 seconds ago) / DE
› Goalinstitute.org (2 mins ago) / IN
› Jachsny.com (3 mins ago) / CA
› Sinsulfatos.com (28 seconds ago) / US
› Thankyoudiscord.com (3 seconds ago) / US
› Talquin.chooseev.com (14 seconds ago) / US
› Propacademy.co.za (1 mins ago) / US
› Husinecrestaurace.cz (29 seconds ago) / SK
› Puplifetoday.com (1 seconds ago) / US
› Proxy.dramonline.org (37 seconds ago) / US
› Ultragenyx.com (1 seconds ago) / US
› Newmadridcountyhealthdept.com (2 mins ago) / US
› Xtech.ae (47 seconds ago) / US
› Nanophos.com (1 seconds ago) / DE
› Quality-life-solutions.com (26 seconds ago) / US
› Project-traker.herokuapp.com (18 seconds ago) / IE
› Inshot-for-pc.com (1 mins ago) / US
Websites Listing
We found Websites Listing below when search with ultragenyx.com on Search Engine
Contact Us - Ultragenyx
Ultragenyx Medical Information Support. 1-888-756-8657, select option #2. [email protected]. Or use this submission form. For Investigator Initiated Sponsored Research (IISR), Investigator Sponsored Trial (IST), or other independent research support information please email UltraPrograms IST Operations at [email protected].
Ultragenyx.comUltragenyx Treatment of Rare and Ultra-rare Genetic …
2022-02-03 · Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2021 Financial Results and Corporate Update. February 3, 2022. Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) February 2, 2022. Read More News. COVID-19 Information. As the COVID-19 pandemic continues to evolve, we are focused on the health and safety of our …
Ultragenyx.comEmil D. Kakkis, M.D., Ph.D. - Ultragenyx
Emil D. Kakkis, M.D., Ph.D. Founder, President and Chief Executive Officer. , Ultragenyx. Dr. Kakkis is Chief Executive Officer, President and a Director of Ultragenyx. He founded Ultragenyx in 2010 to create a company that is uniquely built around a deep and meaningful engagement with patients and their caregivers to fully understand their needs.
Ultragenyx.comRare Disease Patient Services & Treatment Suite - UltraCare
By submitting this form, you agree to allow Ultragenyx and its agents to collect the information provided and to be contacted directly by an Ultragenyx representative. Your information will not be used for any other purpose than for a representative to respond to your information request or for us to send you updates if you have registered to receive them.
Ultracaresupport.comWorking at Ultragenyx
If you have any difficulty using our website and need an accomodation due to a disability, you may contact us by calling: (888) 384-0599 or by emailing us at [email protected]. For electronic email and mail inquiries, please include a description of your requested accommodation, your name and contact information.
Ultra-talent.comJobs - Ultragenyx
If you have any difficulty using our website and need an accommodation due to a disability, you may contact us by calling: (888) 384-0599 or by emailing us at [email protected]. For electronic email and mail inquiries, please include a description of your requested accommodation, your name and contact information.
Ultragenyx.comGeneTx and Ultragenyx Announce First Patient Dosed in ...
2020-03-16 · Ultragenyx is a biopharmaceutical company committed to bringing patients novel products for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no …
Ir.ultragenyx.comUltragenyx Reports Fourth Quarter and Full Year 2021 ...
2022-02-10 · Ultragenyx recognized $55.5 million in Crysvita (burosumab) revenue in the Ultragenyx territories, which includes $50.2 million in collaboration revenue in the North American profit share territory and net product sales in other regions of $5.3 million. Total royalty revenue related to European Crysvita sales were $4.7 million. Dojolvi (triheptanoin) product sales in the …
Stockhouse.comUltragenyx - 27th Annual LANP Conference
Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need …
Lanpconference.comUltragenyx – Entwicklung von Medikamenten für seltene ...
Ultragenyx ist ein forschendes, börsennotiertes biopharmazeutisches Unternehmen mit Sitz in Novato, Kalifornien (USA), das neuartige Arzneimittel zur Behandlung seltener Erkrankungen entwickelt. Der Schwerpunkt liegt dabei auf schweren erblich bedingten Erkrankungen. Seit der Gründung im Jahre 2010 hat Ultragenyx ein breites Portfolio verschiedener Substanzen …
Ultragenyx.deUltragenyx - Privacy Policy
E-mail: [email protected] Modifications. Ultragenyx can change this notice anytime. We will post changes to this notice on the Website so you should read this notice again if you come back to this site at another time. If you visit this Website after we make changes, we will think that you and your parent agree with the rules for the Website and you agree with this notice. If you or your ...
Ultrarareadvocacy.comRegeneron (REGN), Ultragenyx (RARE) Collaborate to ...
2022-01-07 · E-mail Address. StreetInsider.com Top Tickers, 2/19/2022. 1. SPY 2. RSX 3. ROKU 4. INTC 5. SHAK. 6. RDFN 7. TSLA 8. DBX 9. RUN 10. CGNX. Top News Most Read Special Reports. Wall Street ends lower ...
Streetinsider.comWilson Disease Information - Ultragenyx
Wilson Disease (WD) Also known as copper storage disease, hepatolenticular degeneration syndrome, Wilson’s disease. What is it? Wilson disease is a rare genetic disorder that results from an inability to remove excess copper from the body. Too much copper in the body can lead to liver disease as well as neurological (brain) issues. 1.
Ultrarareadvocacy.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
aga22-batumi.com | domain.com | -1 Years, -320 Days |
earshot.org | networksolutions.com | 1 Year, 263 Days |
sheltercluster.org | eurodns.com | -1 Years, -168 Days |
mas-ssf.org | dreamhost.com | -2 Years, -104 Days |
mcctcarbide.com | tucows.com | -2 Years, -140 Days |
dream-stage.net | psi.jp | -2 Years, -153 Days |
nutmegcompanies.com | tucows.com | -2 Years, -184 Days |
gessdubai.com | totalregistrations.com | 85 Days |
eveleighcreations.com | launchpad.com | -2 Years, -120 Days |
easykart.net | key-systems.net | -2 Years, -14 Days |